About Specipig
Specipig is a Healthcare company based in Barcelona (Spain) founded in 2013. It operates as a biomedical research services using swine models are offered by Specipig. Specipig has raised $605.12 thousand across 2 funding rounds from investors including Semen Cardona, Bioempren and Catalan Institute of Finance. Specipig offers products and services including Preclinical Trials and Animal Models. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
Specipig is a CRO specialising in model pigs. It is currently the only company in Europe to offer comprehensive services for biomedical research with this animal model, which include breeding of genetically selected pigs, an analytical laboratory, an operating room and a team of experts in toxicology and proof of concept for new drugs, validation of medical devices, surgical training and research into new surgical techniques. In collaboration with the Government of Catalonia Institute for Research and Technology in Food and Agriculture (IRTA), Specipig is developing its own genetic breed of miniature pigs (which weigh 35 kgs as compared to conventional pigs which weigh 200 kgs approx.), which will be marketed in the near future. They also have conventional Specific Pathogen Free pigs.
- Headquarters Barcelona, Spain
- SectorsHealthcare
- Website specipig.com
- Social LinkedIn X
- Total Equity Funding$605.12K (USD)
in 2 rounds
- Latest Funding Round$605.12K (USD), Seed
Mar 2016
- InvestorsSemen Cardona
& 2 more
Products & Services of Specipig
Specipig offers a comprehensive portfolio of products and services, including Preclinical Trials and Animal Models.
Conducts safety and efficacy evaluations for drugs and devices
Provides pig models for preclinical research and testing
Funding Insights of Specipig
Specipig has successfully raised a total of $605.12K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $605.12 thousand completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $605,119
- Total Rounds 2
- Last Round Seed — $605,119
- First Round $265,833
(Jun 2014)
- Investors Count 3
All 2 funding rounds of Specipig with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2016 | $605,119 | Seed | – | – | |
| Jun 2014 | $265,833 | Debt – Venture | – | – |
3 investors in total: 3 institutional.
Investors in Specipig
Specipig has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Semen Cardona, Bioempren and Catalan Institute of Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investment fund | – | icf.cat | Barcelona, Spain | |
Platform to promote and support biotechnology business projects in Catalonia. | 2009 | bioempren.com | Badalona, Spain | |
Doses of semen for swine artificial insemination are provided. | 1984 | semencardona.com | Cardona, Spain |
Investor details for Specipig
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Specipig
3 dated milestones of Specipig across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Specipig is founded.
- Funding First funding round of $266K.
- Funding Latest funding round, Seed, of $605K.
Competitors of Specipig
Specipig has 9 listed competitors in our database, 4 of them funded. They include TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| transcurebioservices.com | 2012 | Archamps, France | $3.58M | – | Humanized mouse models are developed for preclinical immune drug studies. | |
| genoway.com | 1999 | Lyon, France | $11.55M | – | Provider of transgenic rodent models and customized cell lines for preclinical development | |
| psychogenics.com | 1999 | Tarrytown, United States | – | 124 | Preclinical CRO services for CNS and orphan disorders are offered. | |
| pharmalegacy.com | 2008 | Shanghai, China | – | – | Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas | |
| invivobiosystems.com | 2019 | United States | $8.16M | – | Animal models are supplied for in-vivo analytical services. | |
| noblelifesci.com | 2010 | Woodbine, United States | $335,000 | – | Preclinical contract research organization offering standard GLP and non-GLP services | |
| alphagenesisinc.com | 2003 | Yemassee, United States | – | 143 | Company offering primate models and services for preclinical drug discovery | |
| zeclinics.com | 2013 | Barcelona, Spain | – | – | Zebrafish models for toxicity studies are developed by ZeClinics CRO. | |
| explorabiolabs.com | 2004 | San Diego, United States | – | – | Discovery pharmacology and vivarium services are provided to biotech clients. |
Detailed competitors of Specipig
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Specipig (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Specipig
Specipig was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Specipig is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Specipig is a funded company, having raised a total of $605.12K across 2 funding rounds to date. The company's 1st funding round was a Debt – Venture of $265.83K, raised on Jun 2014.
Specipig is a CRO specialising in model pigs. It is currently the only company in Europe to offer comprehensive services for biomedical research with this animal model, which include breeding of genetically selected pigs, an analytical laboratory, an operating room and a team of experts in toxicology and proof of concept for new drugs, validation of medical devices, surgical training and research into new surgical techniques. In collaboration with the Government of Catalonia Institute for Research and Technology in Food and Agriculture (IRTA), Specipig is developing its own genetic breed of miniature pigs (which weigh 35 kgs as compared to conventional pigs which weigh 200 kgs approx.), which will be marketed in the near future. They also have conventional Specific Pathogen Free pigs.
Specipig's top competitors include GenOway, PsychoGenics and Alpha Genesis.
Specipig offers Preclinical Trials and Animal Models.
Specipig has 3 investors. Key investors include Semen Cardona, Bioempren, and Catalan Institute of Finance.